Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChill Brands Regulatory News (CHLL)

Share Price Information for Chill Brands (CHLL)

Share Price is delayed by 15 minutes
Get Live Data
3.25    0.07 (2.20%)
Bid:
3.00
Ask:
3.50
Spread: 0.50 (16.667%)
Market Cap: £1.70m
CHLL Live PriceLast checked at - London Stock Exchange

Intraday Chill Brands Share Chart

Launch of Dispensary Sales Pilot Programme

12 Oct 2022 08:00

RNS Number : 6172C
Chill Brands Group PLC
12 October 2022
 

12 October 2022

Chill Brands Group plc

("Chill Brands" or the "Company")

 

Launch of Dispensary Sales Pilot Programme

Chill Brands Group, the international consumer packaged goods company, is pleased to announce the launch of its CBD products into select cannabis dispensaries as part of a new sales pilot programme.

The pilot scheme will see Chill Brands' products enter an initial 20 fully licensed dispensaries as the Company gathers sales data and customer insights. Additional locations will be onboarded during Q4 2022. Following the completion of this pilot phase, the Company intends to scale its dispensary sales to additional locations across the United States.

During 2021, dispensaries in Colorado alone generated in excess of US $2 billion from sales of cannabis-based products. Consumers that frequent these stores typically have higher levels of discretionary income than convenience store shoppers, are already aware of and interested in cannabinoids including CBD, and are open to trialing new brands and products. They are supported by expert sales personnel known as 'budtenders', who act as cannabis sommeliers to guide consumers towards suitable products.

The programme will be launched in conjunction with Bellator and Dyspense, both Colorado-based sales and retail logistics companies with specific expertise in cannabis products.

Further updates will be provided as the pilot scheme progresses.

Timothy Ruybal Jr., Founder of Dyspense Technologies, commented:

"Dyspense looks forward to the launch of the Chill brand into Colorado dispensaries, where we have seen a steep increase in CBD only product sales over the last 24 month. Chill products provide a unique alternative for tobacco and THC consumers and we look forward to working with the Company to expand its footprint."

Callum Sommerton, Chief Executive Officer of Chill Brands, commented:

"We are excited to be expanding our US retail distribution footprint once more. This pilot programme is an opportunity to diversify the sales venues in which Chill products can be found. As demand for novel, non-psychoactive products continues to grow, we will be well positioned to offer Chill CBD to target consumers both to complement their cannabis purchases and as a non-intoxicating recreational alternative to THC.

We are grateful to our partners at Bellator and Dyspense for their support, and look forward to working with these industry experts as we seek to scale our operations within the dispensary environment."

-ENDS-

About Chill Brands Group

Chill Brands Group plc (LSE: CHLL, OTCQB: CHBRF) is an international company concerned with the development, production, and distribution of best-in-class hemp-derived CBD products, tobacco alternatives and other consumer packaged goods (CPG) products. The Company operates primarily in the US, where its products are distributed online and via some of the nation's most recognisable convenience retail outlets. The Group's strategy is anchored around lifestyle marketing that is designed to enhance the popularity of its products, channelling visitors to its landmark chill.com website.

Publication on website

A copy of this announcement is also available on the Group's website at http://www.chillbrandsgroup.com

Media enquiries:

Chill Brands Group plc

contact@chillbrandsgroup.com

Allenby Capital Limited (Financial Adviser and Broker)

+44 (0) 20 3328 5656

Nick Harriss/Nick Naylor (Corporate Finance)

Kelly Gardiner (Equity Sales)

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKBBBABDKQKD
Date   Source Headline
29th May 20264:41 pmRNSShare Capital Reorganisation, PDMR & TVR
19th May 20267:00 amRNSUpdated Timetable for Share Capital Reorganisation
13th May 20263:27 pmRNSResult of AGM
13th May 20267:00 amRNSCommercial Update Ahead of AGM
23rd Apr 20267:00 amRNSCommercial Update
20th Apr 20262:00 pmRNSNotice of AGMs & Share Capital Reorganisation
31st Mar 20267:00 amRNSDirectorate change
9th Feb 20267:00 amRNSTrading Update
25th Nov 20257:00 amRNSChange of Auditor
31st Oct 20255:00 pmRNSTotal Voting Rights
23rd Oct 20257:00 amRNSChill Agrees Settlement with Former Advisers
20th Oct 20257:00 amRNSBusiness and strategy update
1st Oct 20255:21 pmRNSHolding(s) in Company
26th Sep 20257:00 amRNSIssue of Equity
19th Sep 20251:30 pmRNSREPLACEMENT-Chill Brands appointed UK Distributor
10th Sep 20257:00 amRNSChill appointed Distributor - ELF Nicotine Pouches
8th Sep 20257:00 amRNSStrategic partnership with SYP Global
5th Sep 202511:00 amRNSHolding(s) in Company
1st Sep 20257:00 amRNSChill Appointed UK Distribution Partner by RELX
22nd Aug 202512:30 pmRNSHolding(s) in Company
11th Aug 20257:45 amRNSCompany Update and Lifting of Suspension
11th Aug 20257:30 amRNSRestoration - Chill Brands Group plc
31st Jul 202512:30 pmRNSInterim Results for the 12 months to 31 March 2025
28th Jul 20257:00 amRNSChange of Accounting Reference Date
11th Jul 20251:00 pmRNSHalf-year Report for the 6 months to 30 Sep 2024
23rd Jun 20257:00 amRNSAnnual Financial Report to 31 March 2024
30th May 20257:00 amRNSUpdate on the publication of financial results
23rd May 20257:00 amRNS£1m raised from issuance of convertible loan notes
24th Apr 20257:00 amRNSFundraising to raise £1m & Update on results
26th Mar 202512:00 pmRNSStatus of audit and publication of accounts
11th Mar 20257:00 amRNSUpdate on Current Business & Proposed Fundraising
19th Dec 20247:00 amRNSCorporate update
9th Dec 20247:00 amRNSCompany Update
30th Sep 20244:30 pmRNSResult of AGM
30th Sep 20247:00 amRNSAGM Statement & Trading Update
5th Sep 20247:00 amRNSDirectorate Change & Notice of AGM
25th Jul 20244:20 pmRNSCommencement of Legal Action
17th Jul 20247:00 amRNSCompany Update & Directorate Changes
10th Jun 20247:00 amRNSDirectorate Change & Company Update
4th Jun 20241:10 pmRNSResult of GM and Board Changes
3rd Jun 20247:53 amRNSSuspension of Trading in Shares
7th May 20245:31 pmRNSPosting of General Meeting Documents
7th May 20242:04 pmRNSNotice of GM
22nd Apr 20247:00 amRNSSuspension of CEO
17th Apr 20243:18 pmRNSReceipt of Requisition Letter
16th Apr 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSInvestor Presentation via Investor Meet Company
31st Jan 20245:00 pmRNSTotal Voting Rights
29th Jan 20247:00 amRNSResponse to Government Proposals
26th Jan 20247:00 amRNSEquity Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.